TFR Capital LLC. Takes $3.23 Million Position in Danaher Corporation $DHR

TFR Capital LLC. acquired a new stake in shares of Danaher Corporation (NYSE:DHRFree Report) during the second quarter, according to its most recent filing with the SEC. The fund acquired 4,490 shares of the conglomerate’s stock, valued at approximately $3,233,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. JPL Wealth Management LLC bought a new stake in shares of Danaher during the third quarter valued at about $25,000. Main Street Group LTD purchased a new stake in shares of Danaher in the first quarter worth about $25,000. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter valued at approximately $26,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher during the fourth quarter valued at approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on DHR shares. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. DZ Bank initiated coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target for the company. Argus reduced their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Finally, Wells Fargo & Company lowered their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $228.91.

View Our Latest Report on Danaher

Danaher Trading Down 0.7%

Shares of DHR opened at $202.51 on Friday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a market capitalization of $142.37 billion, a P/E ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm’s 50 day simple moving average is $193.14 and its 200 day simple moving average is $193.21.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.77 EPS. Sell-side analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.